Molecular Partners Half Year 2022 News Release and Investor Call Details

Rhea-AI Summary

Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN) will release its H1 2022 highlights and financial results on August 25, 2022, at 4:30 pm ET. Following this, an analyst and investor call is scheduled for August 26, 2022, at 8:00 am ET. The call will be webstreamed and available for 90 days post-event. Molecular Partners focuses on DARPin therapeutics, aiming to address challenges in diverse medical fields including ophthalmology, oncology, and infectious diseases.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, will issue a press release summarizing its highlights and financial results for the first half-year of 2022, followed by an analyst & investor call the following day. Please see more details here:

Release date and time

• August 25, 2022, 4:30 pm ET (10:30 pm CET)
  

Call Details:

• August 26, 2022, 8:00 am ET (2:00 pm CET)
  

The half year 2022 results presentation will be webcast live and will be made available on the Company’s website under the investor section. The replay will be available for 90 days following the presentation.

In order to register for the H1 2022 conference call on Friday, August 26, 2pm CET / 8am ET, please dial the following numbers approximately 10 minutes before the start of the presentation:

Switzerland	0800 246787
USA	+1 866 652 5200
Full list of dial-in numbers:	Linked here
Conference ID	Please ask to be joined into the Molecular Partners call

About Molecular Partners AG 
Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com; Find us on Twitter - @MolecularPrtnrs

For further details, please contact:
Seth Lewis
seth.lewis@molecularpartners.com
Tel: +1 781 420 2361

Shai Biran, Ph.D.
shai.biran@molecularpartners.com
Tel: +1 978 254 6286

Thomas Schneckenburger, European IR & Media
thomas.schneckenburger@molecularpartners.com
Tel: +41 79 407 9952

FAQ

What are the upcoming events for Molecular Partners AG?

Molecular Partners AG will announce its H1 2022 financial results on August 25, 2022, followed by an analyst and investor call on August 26, 2022.

When is Molecular Partners AG's H1 2022 results release?

The H1 2022 results will be released on August 25, 2022, at 4:30 pm ET.

How can investors access the Molecular Partners AG conference call?

Investors can access the conference call by dialing in approximately 10 minutes before the start on August 26, 2022, at 8:00 am ET.